8. Read the following statement and write “Yes” or “No” as to whether the person is an
entrepreneur or not.
(a) Ravi made tea for his friends in the office. Everyone liked the tea very much and told him
that he is very good at making tea.
(b) Savita, a house wife, needs extra money for her kids’ tuition. She notices that in the
afternoon, the children coming out of a nearby college look tired and hungry. She makes
refreshing Neembu Pani and samosas and sells them to the students.
(c) Rahul loves dogs. He plays with dogs of his friends’ family. One day when they were going
out-of station, they asked Rahul to take care of their dog. Rahul thought that this was a good
idea, “taking care of dogs when the owner is traveling”. He started his own company which is
like a “hotel for dogs”. When the dog-owners travel, they leave their dogs at this hotel and pay
the company money for each day they take care of the dog. Is Rahul an entrepreneur?
(d) Monica noticed that her neighbours used to face a problem. They had to leave their young
baby behind when they went for work. Monica started going to this house in the evening to
take care of the baby for them. Her neighbours were very happy and used to give her
chocolates for doing that
Answers
Answer:
Increasing Transparency And Confidence Through Real-Time Data Sharing
Source: Lonza Pharma & Biotech
By John Chapin, Senior Automation Engineer, and John Morse, QA Lead, Strategic Growth Investments and Engineering, Lonza Biologics
DNA digital health network (002)
Three industrial revolutions catalyzed by steam, electricity, and the computer, respectively, have occurred over the course of history and drastically changed the landscape of how goods are manufactured. The next transformation taking shape is being dubbed as Industry 4.0, which is the digitization of manufacturing utilizing data, machine learning, and artificial intelligence. Interconnectivity, real-time data sharing, and automation are used to increase transparency across an organization’s people, production line, and in the supply chain, leading to increased efficiency in manufacturing. This movement is fueled by more informed, and eventually autonomous, decision making as automation spreads throughout the business functions. A digitally connected plant is required for this transformation to occur.
VIEW THE ARTICLE!
Signing up provides unlimited access to:
Trend and Leadership Articles
Case Studies
Extensive Product Database
Premium Content
Lonza Pharma & Biotech
Contact The Supplier
Contact Details
Company Profile
MORE FROM Lonza Pharma & Biotech
Are You Prepared To Meet The Diverse Manufacturing Needs Of Today’s Biopharma Market?
Are You Prepared To Meet The Diverse Manufacturing Needs Of Today’s Biopharma Market?
Meeting the needs of the modern biomanufacturing landscape requires a combination of technology and digital solutions working together to effectively and efficiently meet your goals.
Because Scale Matters: A Flexible Approach To Demand Uncertainty
Mid-volume capacity bioreactors offeragility in an unpredictable industry and balancethe cost of goods as a program prepares to launch.
Gene To IND In 12 Months Without Increased Risk
With a variety of gene to IND programs on the market, it is important you carefully assess which program matches your technical expectations as well as your risk adversity profile.
Will Your CMC Strategy Ensure Your Project Aligns With Its Clinical Path Requirements And Timeline?
Manufacturers must understand the challenges associated with creating a CMC strategy in today’s crowded and diverse market and the expertise and resources needed to successfully execute it.
A Stepwise Approach To CMC Planning For A Biologics License Application
Lonza understands the challenges of designing a CMC strategy and has developed a structured and stepwise approach to planning that is tailored to our customers’ product, process, timelines, and...
Navigating CMC Requirements For Accelerated Development
A Q&A With The Experts: Reducing Timelines From Gene To IND
Science Of Scale For Spray Dried Intermediates
Answering Today’s Pharma Dilemma Of Build Or Buy
A Q&A: Achieving Biologics License Application Success Using A Structured Approach
Achieving Biologics License Application Success Using A Structured Approach
Technology Selection To Enhance Bioavailability
This website uses cookies to ensure you get the best experience on our website. Learn more
Got it!
Partner With Us
Request More Information
Our Partners
Subscribe
Newsletter
Life Science Connect
Biosimilar Development
Cell & Gene
Clinical Leader
Drug Discovery
Laboratory Network
Life Science Leader Magazine
Med Device Online
Outsourced Pharma
Pharmaceutical Online
Editorial
Archived Newsletters
Article Reprints
Editorial Submission Guidelines
Editorial Contributors
Events
CMO Leadership Awards
CRO Leadership Awards
Learn More
About Us
Contact Us
Work For Us
Copyright © 1996-2021 VertMarkets, Inc. All Rights Reserved. Terms of Use. Privacy Statement. Subscriber Request Form. Don't sell my information
notification icon